Switch to:
Also traded in: Australia, Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 1/10

vs
industry
vs
history
Cash-to-Debt 0.07
UNIS's Cash-to-Debt is ranked lower than
96% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. UNIS: 0.07 )
Ranked among companies with meaningful Cash-to-Debt only.
UNIS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.51 Max: N/A
Current: 0.07
Equity-to-Asset -1.42
UNIS's Equity-to-Asset is ranked lower than
98% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. UNIS: -1.42 )
Ranked among companies with meaningful Equity-to-Asset only.
UNIS' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.42  Med: 0.52 Max: 0.79
Current: -1.42
-1.42
0.79
Piotroski F-Score: 3
Altman Z-Score: -11.24
Beneish M-Score: -6.39
WACC vs ROIC
5.93%
-7823.45%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % -795.89
UNIS's Operating Margin % is ranked lower than
93% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.65 vs. UNIS: -795.89 )
Ranked among companies with meaningful Operating Margin % only.
UNIS' s Operating Margin % Range Over the Past 10 Years
Min: -2225.96  Med: -611.25 Max: -1.77
Current: -795.89
-2225.96
-1.77
Net Margin % -738.56
UNIS's Net Margin % is ranked lower than
93% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.14 vs. UNIS: -738.56 )
Ranked among companies with meaningful Net Margin % only.
UNIS' s Net Margin % Range Over the Past 10 Years
Min: -2303.97  Med: -611.76 Max: -2.59
Current: -738.56
-2303.97
-2.59
ROA % -87.06
UNIS's ROA % is ranked lower than
93% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. UNIS: -87.06 )
Ranked among companies with meaningful ROA % only.
UNIS' s ROA % Range Over the Past 10 Years
Min: -109.51  Med: -61.32 Max: -1.74
Current: -87.06
-109.51
-1.74
ROC (Joel Greenblatt) % -113.33
UNIS's ROC (Joel Greenblatt) % is ranked lower than
77% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.86 vs. UNIS: -113.33 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
UNIS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -156.25  Med: -100.44 Max: -4.02
Current: -113.33
-156.25
-4.02
3-Year Revenue Growth Rate -32.80
UNIS's 3-Year Revenue Growth Rate is ranked lower than
92% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. UNIS: -32.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
UNIS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -48  Med: 47.15 Max: 142.9
Current: -32.8
-48
142.9
3-Year EBITDA Growth Rate -54.70
UNIS's 3-Year EBITDA Growth Rate is ranked lower than
96% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.10 vs. UNIS: -54.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
UNIS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -54.7  Med: 118.9 Max: 154.7
Current: -54.7
-54.7
154.7
3-Year EPS without NRI Growth Rate -55.10
UNIS's 3-Year EPS without NRI Growth Rate is ranked lower than
95% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. UNIS: -55.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
UNIS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -55.1  Med: 124.1 Max: 239.1
Current: -55.1
-55.1
239.1
GuruFocus has detected 7 Warning Signs with Unilife Corp $UNIS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» UNIS's 10-Y Financials

Financials (Next Earnings Date: 2017-05-09 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

UNIS Guru Trades in Q2 2015

Jim Simons 27,774 sh (New)
Ron Baron 333,477 sh (-52.49%)
» More
Q3 2015

UNIS Guru Trades in Q3 2015

Jim Simons Sold Out
Ron Baron Sold Out
» More
Q4 2015

UNIS Guru Trades in Q4 2015

Jim Simons 352,501 sh (New)
» More
Q1 2016

UNIS Guru Trades in Q1 2016

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with UNIS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:AMEX:RVP, AMEX:ISR, NAS:CASM, NAS:ATEC, NAS:BLFS, AMEX:DXR, AMEX:MLSS, NAS:PDEX, OTCPK:LDSYF, AMEX:INFU, NAS:BMRA, OTCBB:NEPH, NAS:LENS, OTCPK:REPR, NAS:SKLN, OTCPK:IGAP, OTCPK:STXS, OTCPK:UEEC, NAS:DXTR, NAS:AKER » details
Traded in other countries:UNS.Australia, 4UL1.Germany, UNISZ.USA,
Unilife Corp is a designer, manufacturer and supplier of injectable drug delivery systems. Its product include pre-filled syringes, wearable injectors, disposable & reusable auto-injectors, drug reconstitution delivery systems & other systems.

Unilife Corp was incorporated under the laws of the State of Delaware in 2009 and is based in the Commonwealth of Pennsylvania. The Company is a designer, manufacturer, and supplier of injectable drug delivery systems that can enhance and differentiate the injectable products of its pharmaceutical and biotechnology customers. It has developed several product platforms, including its Unifill platform of pre-filled syringes, its LISA smart reusable and RITA disposable auto-injectors, its EZMix platform of drug reconstitution delivery systems, and its Ocu-ject, Ocu-mix, and Depot-ject ocular delivery systems. The Company's product portfolio comprises of proprietary product platforms, including wearable injectors, insulin delivery systems, disposable and reusable auto-injectors, pre-filled syringes, drug reconstitution delivery systems, ocular delivery systems and other systems for the targeted delivery of injectable therapies.

Ratios

vs
industry
vs
history
PE Ratio 0.06
UNIS's PE Ratio is ranked higher than
99% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.58 vs. UNIS: 0.06 )
Ranked among companies with meaningful PE Ratio only.
UNIS' s PE Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.08 Max: 0.14
Current: 0.06
0.05
0.14
PE Ratio without NRI 0.06
UNIS's PE Ratio without NRI is ranked higher than
99% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. UNIS: 0.06 )
Ranked among companies with meaningful PE Ratio without NRI only.
UNIS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0.05  Med: 0.08 Max: 0.14
Current: 0.06
0.05
0.14
PS Ratio 1.50
UNIS's PS Ratio is ranked higher than
71% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. UNIS: 1.50 )
Ranked among companies with meaningful PS Ratio only.
UNIS' s PS Ratio Range Over the Past 10 Years
Min: 0.69  Med: 23.55 Max: 85.65
Current: 1.5
0.69
85.65
Current Ratio 0.87
UNIS's Current Ratio is ranked lower than
93% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.37 vs. UNIS: 0.87 )
Ranked among companies with meaningful Current Ratio only.
UNIS' s Current Ratio Range Over the Past 10 Years
Min: 0.32  Med: 1.41 Max: 8.01
Current: 0.87
0.32
8.01
Quick Ratio 0.87
UNIS's Quick Ratio is ranked lower than
81% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. UNIS: 0.87 )
Ranked among companies with meaningful Quick Ratio only.
UNIS' s Quick Ratio Range Over the Past 10 Years
Min: 0.32  Med: 1.41 Max: 7.77
Current: 0.87
0.32
7.77
Days Sales Outstanding 94.90
UNIS's Days Sales Outstanding is ranked lower than
81% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. UNIS: 94.90 )
Ranked among companies with meaningful Days Sales Outstanding only.
UNIS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.71  Med: 49.5 Max: 133.99
Current: 94.9
0.71
133.99

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -22.20
UNIS's 3-Year Average Share Buyback Ratio is ranked lower than
84% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. UNIS: -22.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UNIS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -30.1  Med: -20.3 Max: 31.4
Current: -22.2
-30.1
31.4

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.06
UNIS's Price-to-Median-PS-Value is ranked higher than
98% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. UNIS: 0.06 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
UNIS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.03  Med: 1.05 Max: 2.26
Current: 0.06
0.03
2.26
Earnings Yield (Greenblatt) % -44.92
UNIS's Earnings Yield (Greenblatt) % is ranked lower than
91% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. UNIS: -44.92 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
UNIS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -56.5  Med: 53.35 Max: 128
Current: -44.92
-56.5
128

More Statistics

Revenue (TTM) (Mil) $11.21
EPS (TTM) $ 32.36
Beta-1.36
Short Percentage of Float9.31%
52-Week Range $1.58 - 8.40
Shares Outstanding (Mil)18.15
» More Articles for NAS:UNIS

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 10 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 29 2012 
Weekly CEO Buys Highlight: TRNO, UNIS, GFN Jan 21 2012 
Weekly CEO Buys Highlight: UNIS, TRNO, WINA, SXC, CTFO Jan 14 2012 
Weekly CEO Buys Highlight: UNIS, ESL, TREE, TPGI, VAC Jan 08 2012 
Weekly CEO Buys Highlight: BFS, NCT, NL, UNIS, MSCI Oct 01 2011 
Weekly CEO Buys Highlight: RCL, CIT, PNK, EXE, UNIS Aug 27 2011 
Weekly CEO Buys Highlight: DELL, DEER, BGCP, UNIS, KSWS Mar 19 2011 
Unilife Corp. (UNIS) CEO Alan Shortall buys 105,452 Shares Mar 17 2011 
Unilife Corp. Reports Operating Results (10-Q) Feb 14 2011 

More From Other Websites
Unilife Corp. :UNIS-US: Earnings Analysis: Q2, 2017 By the Numbers : March 16, 2017 Mar 16 2017
UNILIFE CORP Financials Feb 15 2017
Q2 2017 Unilife Corp Earnings Release - After Market Close Feb 10 2017
Unilife reports 2Q loss Feb 10 2017
Unilife reports 2Q loss Feb 10 2017
UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 09 2017
UNILIFE CORP Files SEC form 10-Q, Quarterly Report Feb 09 2017
Lifshitz & Miller LLP Announces Investigation of Anthera Pharmaceuticals, Inc., Arctic Cat Inc.,... Feb 03 2017
UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jan 31 2017
ETFs with exposure to Unilife Corp. : January 20, 2017 Jan 20 2017
Bragar Eagel & Squire, P.C. Is Investigating Unilife Corporation (NASDAQ:UNIS) on Behalf of... Jan 13 2017
ETFs with exposure to Unilife Corp. : January 6, 2017 Jan 06 2017
ETFs with exposure to Unilife Corp. : December 23, 2016 Dec 23 2016
UNILIFE CORP Files SEC form 8-K/A, Regulation FD Disclosure, Financial Statements and Exhibits Dec 20 2016
UNILIFE CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Dec 16 2016
UNILIFE CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 15 2016
ETFs with exposure to Unilife Corp. : December 12, 2016 Dec 12 2016
ETFs with exposure to Unilife Corp. : December 1, 2016 Dec 01 2016
Unilife Corp. :UNIS-US: Earnings Analysis: Q1, 2017 By the Numbers : November 30, 2016 Nov 30 2016
Edited Transcript of UNIS earnings conference call or presentation 2-Nov-16 8:30pm GMT Nov 23 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)